<< Back to all Blogs

Archives

Array
(
    [Jan 2012] => /2012/01/
    [Dec 2011] => /2011/12/
    [Nov 2011] => /2011/11/
    [Oct 2011] => /2011/10/
    [Sep 2011] => /2011/09/
    [Aug 2011] => /2011/08/
    [Jul 2011] => /2011/07/
)

My Blog Stats

Date Started: Jul 28, 2011
Entries: 558
Comments: 0
Total Visits: 29,550

Home > (ANGO, GBLHF.PK, CTRN, MJGCF.PK, AMAT) Stock under Consideration by CRWEWallStre

(ANGO, GBLHF.PK, CTRN, MJGCF.PK, AMAT) Stock under Consideration by CRWEWallStre

September 30th, 2011 at 02:01 pm

AngioDynamics, Inc. (Nasdaq:ANGO) announced the Company has completed patient enrollment in its multi-center European prospective NanoKnife(R) System trial (ONC-205) for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. The purpose of this Company-sponsored trial is to evaluate the safety and efficacy of the NanoKnife System for the treatment of early-stage HCC. Eligibility was based on subjects having one to three tumors of a size no greater than 3 cm. Study subjects are allowed one retreatment with the NanoKnife System.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21555

Posted in Investing | 0 Comments »

0 Responses to “(ANGO, GBLHF.PK, CTRN, MJGCF.PK, AMAT) Stock under Consideration by CRWEWallStre”

(Note: If you were logged in, we could automatically fill in these fields for you.)

Name:	*
Email:	Will not be published.
	Subscribe: Notify me of additional comments to this entry.
URL:
Verification:	* Please spell out the number 4. [ Why? ]

vB Code: You can use these tags: [b] [i] [u] [url] [email]

Wallstreet123's Personal Finance Blog

(ANGO, GBLHF.PK, CTRN, MJGCF.PK, AMAT) Stock under Consideration by CRWEWallStre

0 Responses to “(ANGO, GBLHF.PK, CTRN, MJGCF.PK, AMAT) Stock under Consideration by CRWEWallStre”

Leave a Reply